Sageworth Trust Company of South Dakota’s Integra LifeSciences IART Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35	Closed	-$2.01K	–	118
2023 Q1	$2.01K	Hold	35	–	–	﹤0.01%	191
2022 Q4	$2K	Hold	35	–	–	﹤0.01%	206
2022 Q3	$1K	Sell	35 -21	-38%	-$1.08K	﹤0.01%	224
2022 Q2	$3K	Hold	56	–	–	0.01%	305
2022 Q1	$4K	Sell	56 -76	-58%	-$5K	0.01%	322
2021 Q4	$9K	Buy	+132	New	+$8.93K	0.01%	401

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sageworth Trust Company of South Dakota's IART Position: Q2 2023 in Review

Sageworth Trust Company of South Dakota sold out of Integra LifeSciences (IART) in Q2 2023, closing a stake of 35 shares — an estimated $2.01K sold.

Sageworth Trust Company of South Dakota first reported a position in IART in Q4 2021 and held it in 6 quarters. The position peaked at $9K in Q4 2021. 283 funds tracked by Wall St. Rank hold IART as of Q2 2023.

Sageworth Trust Company of South Dakota reported no remaining Integra LifeSciences position as of Q2 2023 after selling out during the quarter.
Sageworth Trust Company of South Dakota sold 35 Integra LifeSciences shares in Q2 2023, an estimated $2.01K.
Sageworth Trust Company of South Dakota first reported a position in Integra LifeSciences in Q4 2021 and held it in 6 quarters.
Sageworth Trust Company of South Dakota's Integra LifeSciences position peaked at $9K in Q4 2021.
283 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2023.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q2 2023, filed 3 Aug 2023.